Reunion Neuroscience Inc.’s (NASDAQ: REUN) Take-Private Agreement and Its Impact on Mental Health Solutions
Marker Therapeutics, Inc. (NASDAQ: MRKR) Unveils Exciting Pre-Clinical Findings of MT-601 T Cell Therapy in Lymphoma Cells
Aclarion Inc (NASDAQ: ACON): A Breakthrough Partnership
Onfolio Holdings (NASDAQ: ONFO) Unleashing the Power of AI
Wearable Devices Ltd. (NASDAQ: WLDS) Breaking Boundaries with AI
Enveric Biosciences (NASDAQ: ENVB) Pioneering the Future of Anxiety Disorder Treatment
Amgen (NASDAQ: AMGN) and TScan Therapeutics, Inc. (NASDAQ: TCRX) Secure Partnership
ContraFect Corp (NASDAQ: CFRX): A Low Float Runner
Magoceuticals Inc. (NASDAQ: MGRX) Climbing Up The Charts
Aemetis Inc. (NASDAQ: AMTX) Pioneers Renewable Fuel Market with EPA Approval
GSI Technology, Inc. (NASDAQ: GSIT): Pure AI Play Transforming Semiconductor Memory Solutions for Efficient AI Processing
Chinese Nasdaq listings the next meme stock rally?
IN8bio, Inc (NASDAQ: INAB): Our Biotech Focus Stock
CohBar Inc. (NASDAQ: CWBR) and Morphogenesis Join Hands to Create TuHURA Biosciences
NeoGames S.A. (NASDAQ: NGMS) Acquired for $1.2B as Gaming Sector Takes a Bullish Turn
CTI BioPharma (NASDAQ: CTIC) Rings The Register
Quhuo Ltd. (NASDAQ: QH) Rockets Up The Charts
Applied Digital (NASDAQ: APLD) Secures Lucrative $180M Contract and Fuels AI’s Bullish Trajectory
Trevena (NASDAQ: TRVN): A Biotech Low Float Runner
ETAO International Co., Ltd. (NASDAQ: ETAO): An AI Healthcare Opportunity
On April 27, 2023, shares of ContraFect Corp (NASDAQ: CFRX) skyrocketed by 125% in pre-market trading, which is quite unusual. Although the surge may be linked...
Reunion Neuroscience (NASDAQ: REUN) shares jump 119% as they announce an exciting new development. The clinical-stage biopharmaceutical company has entered...